Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-20-000010)

Filing Details

Accession Number:: 0000711377-20-000010
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-12 16:09:25
Reporting Period:: 2020-02-11

Accepted Time:: 2020-02-12 16:09:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517426	J. Steven Quinlan	620 Lesher Place Lansing MI 48912	Vice President & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-11	12,103	$40.46	25,573	No	4	M	Direct
Common Stock	Disposition	2020-02-11	12,103	$72.00	13,470	No	4	S	Direct
Common Stock	Acquisiton	2020-02-12	899	$40.46	14,369	No	4	M	Direct
Common Stock	Disposition	2020-02-12	899	$72.25	13,470	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2020-02-11	12,103	$0.00	12,103	$40.46
Common Stock	Common Stock (Right to Buy)	Disposition	2020-02-12	899	$0.00	899	$40.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
149,697		2021-10-29	No	4	M	Direct
148,798		2021-10-29	No	4	M	Direct

Footnotes

Options were granted 9/29/2016, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant